Wood Tarver Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$352K Buy
1,620
+35
+2% +$7.76K 0.1% 116
2025
Q4
$362K Hold
1,585
0.1% 115
2025
Q3
$366K Hold
1,585
0.11% 112
2025
Q2
$294K Hold
1,585
0.09% 119
2025
Q1
$332K Hold
1,585
0.11% 100
2024
Q4
$281K Buy
+1,585
New +$291K 0.09% 112

Other funds holding ABBV

Wood Tarver Financial Group's ABBV Position: Q1 2026 in Review

Wood Tarver Financial Group increased its AbbVie (ABBV) stake by 2.2% in Q1 2026, buying an estimated $7.76K and bringing the position to 1,620 shares worth $352K. The position accounts for 0.1% of the portfolio, ranked #116.

Wood Tarver Financial Group first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $366K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wood Tarver Financial Group held 1,620 shares of AbbVie worth $352K as of Q1 2026.
  • Wood Tarver Financial Group bought 35 AbbVie shares in Q1 2026, an estimated $7.76K.
  • AbbVie made up 0.1% of Wood Tarver Financial Group's portfolio in Q1 2026, its #116 holding.
  • Wood Tarver Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Wood Tarver Financial Group's AbbVie position peaked at $366K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wood Tarver Financial Group's 13F filing for Q1 2026, filed 12 May 2026.